Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.
Abeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for rare and serious diseases. Crunchbase notes its earlier work on gene therapies for Sanfilippo syndrome types A and B.
Abeona Therapeutics was founded in 1989 by Douglas McCarty, Haiyan Fu.
Source: Crunchbase.
Traffic estimates from Semrush, latest month.
Abeona Therapeutics may be growing as the company is potentially approaching a major achievement in its business. This milestone could signify a positive development in its operations or product pipeline. The anticipation of this event suggests that there may be significant advancements or positive changes that could contribute to the company's growth. Furthermore, the attention from financial news outlets indicates that there is a noteworthy level of interest in the company's progress, which could be reflective of positive performance or expectations.
Source: Crunchbase growth insight.
“Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for rare & serious diseases. Learn more!” abeonatherapeutics.com
Source: company website, checked 2026-10-26.
Search verified work emails and direct dials for people at abeonatherapeutics.com.
Or explore the full B2B database and filter by biotechnology companies.